A recent study represents how an estimated 4.95 million people who died in 2019 suffered from at least one drug-resistant infection and AMR directly caused 1.27 million of those deaths. (1) Novel resistance mechanisms are evolving and spreading rapidly, threatening the healthcare system’s ability to treat common infectious diseases. (2) When we take a step back and assess the current pool, it is evident that each one of us is at risk from AMR which is a major threat to global health, food security, and development in today’s reality. (3)
Pfizer is spearheading the movement against AMR in India
We at Pfizer, are aware that nurses play a critical role in ensuring that good antimicrobial stewardship and infection control measures are practiced in hospitals across the nation. Our goal is to raise effective awareness of AMR and the major threat it poses to modern healthcare. In our journey to achieve this goal, we have supported the launch of a first-of-its-kind multi-lingual learning platform, OPEN—the Online Platform for Education among Nurses!
The introduction of the OPEN-AMR program further strengthens Pfizer’s Project Parivartan, a program focused on addressing the current challenges in Infection Prevention and Control (IPC). The OPEN-AMR program aligns with Project Parivartan’s six-pronged goal which focuses on key aspects such as:
At present Project Parivartan is helping transform 11 hospitals across 7 states such as Maharashtra, Uttar Pradesh, and Tamil Nadu amongst others. The aim of the program is to demonstrate a measurable improvement in key Infection Prevention Control (IPC) parameters in these mid-sized hospitals.
How will the platform help?
OPEN-AMR is a web-based platform that can be accessed by nurses across the country in seven different languages: English, Hindi, Malayalam, Tamil, Telugu, Kannada, and Marathi. The courses on the platform have been curated by experts and are available free of cost to nurses and hospitals.
(1) Murray CJ, Ikuta KS, Sharara F, Swetschinski L, Aguilar GR, Gray A, Han C, Bisignano C, Rao P, Wool E, Johnson SC. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The Lancet. 2022 Feb 12;399(10325):629-55.
(2) Ventola CL. The antibiotic resistance crisis: part 1: causes and threats. Pharmacy and therapeutics. 2015 Apr;40(4):277.
(3) Prestinaci F, Pezzotti P, Pantosti A. Antimicrobial resistance: a global multifaceted phenomenon. Pathogens and global health. 2015 Oct 3;109(7):309-18.